English
Chinese
French
Arabic
Spanish
CHU PHARMA Makes Appearance at API China 2026
CHU PHARMA Makes Appearance at API China 2026 in WuhanWuhan, Nov 11, 2026 — The 95th API China kicks off at Wuhan International Expo Center. CHU PHARMA showcases its portfolio of high-quality APIs and pharmace···
CHU Pharma Launches Export Business for Narcotic and Psychotropic Drugs, Expands Global Controlled‑Drug Market
Recently, CHU Pharma (Xi’an) Pharmaceutical Technology Co., Ltd. announced the official launch of export business for narcotic and psychotropic drugs, expanding its global pharmaceutical product portfolio and ···
CHU PHARMA Participates in CPHI China and API China, Two Major Annual Exhibitions, to Consolidate Industry Brand Influence
CHU PHARMA exhibited at both CPHI Shanghai in the first half of the year and API China in the autumn, showcasing its three major business segments: generic drug APIs, innovative GLP-1 APIs, and customized injec···
CHU PHARMA Participates in Pharmaceutical Africa, Expanding into Emerging Markets in Kenya and Tanzania
The company participated in Pharmaceutical Africa for the second time, focusing on expanding into East Africa in addition to its traditional West African market. The company specifically promoted its GLP-1 weig···
Launching the Official Made-in-China Store, Establishing a Regular Overseas Customer Acquisition Platform for B2B
CHU PHARMA has officially joined the Made-in-China Gold Member Store, fully listing products across four major sections: APIs, Injectable OEM, CDMO Customization, and Plant Extracts. Simultaneously, COA quality···
API China Showcases GLP-1 APIs, Receives Custom R&D Inquiries from Europe and America
The 90th API China Autumn Exhibition was held in Guangzhou. The company's core products were promoted as telpolide API and olfoglitazone tablet OEM, precisely targeting the formulation customization needs o···
Completes Sample Development and Finalization of Tirzepatide and Orforglipron APIs, Entering the High-End GLP-1 Weight Loss Market
Leveraging the technological accumulation of its university-industry joint laboratory, the company has completed the small-scale sample synthesis and purity determination of two core weight loss and blood sugar···
CHU PHARMA Donates Medicines to Mali Ministry of Health, Supporting Local Healthcare Development
CHU PHARMA traveled to the offices of relevant health authorities in Mali's capital, Mali, to formally hand over a donation of medical supplies to the Malian Ministry of Health and Social Affairs. Officials···
Launching Drug Registration Document Assistance Services in Guinea and Mali, Deepening the West African Pharmaceutical Market (Available for Essential Needs)
The company's Foreign Trade Division is focusing on the non-French-speaking markets in West Africa, launching a dedicated service for handling import registration documents for injectable COPPs and pharmace···